Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Knogletab under lavdosis-glukokortikoidbehandling hos patienter med polymyalgia rheumatica. En dobbeltblind, prospektiv sammenligning mellem prednisolon og deflazacort

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. The effect of antidepressants on brain volume

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Nyt studie viser, at motion beskytter mod depression

    Publikation: Bidrag til tidsskriftBidrag til avis - Kommentar/debatFormidling

  3. Forebyggelse og behandling af cytomegalovirusinfektion hos gravide og nyfødte

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Groin hernia in children

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Boganmeldelse: Min mor var besat

    Publikation: Bidrag til tidsskriftBidrag til avis - AnmeldelseFormidling

Vis graf over relationer

The aim of the study was to compare the long term effects of low dosage prednisolone or deflazacort treatment on bone mass in patients with polymyalgia rheumatica. The subjects were 30 patients with newly diagnosed polymyalgia rheumatica, who were allocated to treatment with prednisolone or deflazacort. Bone Mineral Content (BMC) was measured in the lumbar spine (L-BMC) and distal forearm (A-BMC) before treatment and three, six and 12 months after the start of treatment. After three months the decrease in L-BMC was significantly greater in the deflazacort group than in the prednisolone group (p < 0.05), but at six and 12 months there was not a significant difference between the two groups. There was a significant loss of BMC in all patients after 12 months: a 6.4% loss in L-BMC and a 1.8% loss in A-BMC. In conclusion, this low dose study failed to reveal any calcium sparing property of deflazacort compared with prednisolone.

Bidragets oversatte titelBone loss during low dose glucocorticoid treatment in patients with polymyalgia rheumatica. A double-blind, prospective comparison between prednisolone and deflazacort
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind159
Udgave nummer30
Sider (fra-til)4641-4
Antal sider4
ISSN0041-5782
StatusUdgivet - 21 jul. 1997

    Forskningsområder

  • Aged, Anti-Inflammatory Agents, Bone Density, Double-Blind Method, Female, Humans, Immunosuppressive Agents, Male, Middle Aged, Polymyalgia Rheumatica, Prednisolone, Pregnenediones, Time Factors

ID: 45104997